The University of Texas Health Science Center at Houston; McGovern Medical School

Houston, Texas 77030

4 studies enrolling now · 9 studies all time

What they study most

High-grade Splenic Injuries, Huntington Disease, Huntington's Disease, Huntingtons Disease, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Multiple Sclerosis, Parkinson Disease, Progressive Pulmonary Fibrosis

Studies at this site

• Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis — Recruiting now
• Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) — Recruiting now
• A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease — Recruiting now
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease — Enrolling by invitation
• Embolization of the Splenic Artery After Trauma — Completed
• A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD) — Completed
• Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease — Completed
• A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease — Completed
• An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington's Disease Participants Who Participated in Prior Roche and Genentech Sponsored Studies — Completed